1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Tethys Invest

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Type

Investment Company

Location

Paris France

Alternative Asset Classes

PE

Established

2016

Firm Ownership

Captive Arm – Corporate

Investment Team Staff

Total Staff

-
Tethys Invest is an investment company that makes buyout investments into French companies that operate in the health, medical research, and life sciences industries in the UK. Tethys Invest is the investment arm of the Bettencourt-Meyers family (L'Oreal group).
Asset Class No. of Funds Currently Managed Funds Raised in Last 10 Years Est. Dry Powder Strategies
Private Equity - Buyout, Growth
Real Estate - -
Private Debt - -
Infrastructure - -
Natural Resources - -
Asset Class No. of Funds Currently Managed AuM Date of AuM Strategies
Hedge Funds 0 -

Want to see more?

Request a demo for full access to this profile.

2 Known Decision Makers

Contact Name Position Location Email Telephone Asset Class
Investment Director Paris, France PE
Managing Director Paris, France PE

Showing 2 of 2 known decision makers at Tethys Invest

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.